Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 99,802 | 87,069 | 66,467 | 59,867 | 43,484 |
| Cost of Goods | 56,046 | 46,355 | 34,730 | 33,031 | 24,056 |
| Gross Profit | 43,756 | 40,714 | 31,737 | 26,836 | 19,428 |
| Operating Expenses | 49,437 | 38,851 | 29,293 | 25,656 | 19,893 |
| Operating Income | -5,635 | 2,218 | 3,174 | 1,211 | -409 |
| Interest Expense | 854 | 985 | 989 | 1,146 | 768 |
| Other Income | 2,000 | 56 | 0 | 0 | 0 |
| Pre-tax Income | -4,489 | 1,289 | 2,185 | 65 | -1,177 |
| Income Tax | -1,954 | 157 | 152 | N/A | N/A |
| Net Income Continuous | -2,535 | 1,132 | 2,033 | 65 | -1,177 |
| Net Income | $-2,535 | $1,132 | $2,033 | $65 | $-1,177 |
| EPS Basic Total Ops | -0.04 | 0.02 | 0.04 | 0.00 | -0.03 |
| EPS Basic Continuous Ops | -0.04 | 0.02 | 0.04 | 0.00 | -0.03 |
| EPS Diluted Total Ops | -0.04 | 0.02 | 0.04 | 0.00 | -0.03 |
| EPS Diluted Continuous Ops | -0.04 | 0.02 | 0.04 | 0.00 | -0.03 |
| EBITDA(a) | $1,507 | $7,924 | $7,635 | $5,067 | $1,716 |